TY - JOUR T1 - Transition from childhood to adulthood in coeliac disease: the Prague consensus report JF - Gut JO - Gut DO - 10.1136/gutjnl-2016-311574 SP - gutjnl-2016-311574 AU - Jonas F Ludvigsson AU - Lars Agreus AU - Carolina Ciacci AU - Sheila E Crowe AU - Marilyn G Geller AU - Peter H R Green AU - Ivor Hill AU - A Pali Hungin AU - Sibylle Koletzko AU - Tunde Koltai AU - Knut E A Lundin AU - M Luisa Mearin AU - Joseph A Murray AU - Norelle Reilly AU - Marjorie M Walker AU - David S Sanders AU - Raanan Shamir AU - Riccardo Troncone AU - Steffen Husby Y1 - 2016/04/18 UR - http://gut.bmj.com/content/early/2016/04/26/gutjnl-2016-311574.abstract N2 - The process of transition from childhood to adulthood is characterised by physical, mental and psychosocial development. Data on the transition and transfer of care in adolescents/young adults with coeliac disease (CD) are scarce. In this paper, 17 physicians from 10 countries (Sweden, Italy, the USA, Germany, Norway, the Netherlands, Australia, Britain, Israel and Denmark) and two representatives from patient organisations (Association of European Coeliac Societies and the US Celiac Disease Foundation) examined the literature on transition from childhood to adulthood in CD. Medline (Ovid) and EMBASE were searched between 1900 and September 2015. Evidence in retrieved reports was evaluated using the Grading of Recommendation Assessment, Development and Evaluation method. The current consensus report aims to help healthcare personnel manage CD in the adolescent and young adult and provide optimal care and transition into adult healthcare for patients with this disease. In adolescence, patients with CD should gradually assume exclusive responsibility for their care, although parental support is still important. Dietary adherence and consequences of non-adherence should be discussed during transition. In most adolescents and young adults, routine small intestinal biopsy is not needed to reconfirm a childhood diagnosis of CD based on European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) or North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) criteria, but a biopsy may be considered where paediatric diagnostic criteria have not been fulfilled, such as, in a patient without biopsy at diagnosis, additional serology (endomysium antibody) has not been performed to confirm 10-fold positivity of tissue transglutaminase antibodies or when a no biopsy strategy has been adopted in an asymptomatic child. ER -